-- 瑞銀表示,預計週三發布的4月貨幣政策報告(MPR)將包含一篇專欄,分析油價衝擊對加拿大經濟前景的影響。 在1月份的貨幣政策報告(MPR)中,加拿大央行假設:“在預測期內,布蘭特原油價格預計為每桶60美元,西德克薩斯中質原油為每桶55美元,加拿大西部精選原油為每桶45美元。這些價格比10月份報告中的假設低5美元。” 布蘭特原油期貨價格預計到2026年12月將穩定在每桶82美元左右,到2027年12月將穩定在每桶75美元左右。瑞銀在致客戶的報告中寫道,最新的預測可能會進行調整,以反映油價上漲的預期。 瑞銀預計其核心通膨預測不會有太大變化,這不僅是基於3月的數據,也是因為模型顯示能源衝擊對加拿大核心價格的影響相對有限。 該銀行預測,加拿大央行將下調第一季國內生產毛額成長預期,這可能會對其年度成長預期造成影響,具體取決於下調幅度以及成長是否會重新分配。 加拿大央行週一也宣布任命兩位新的副行長,此前副行長里斯·門德斯將於4月10日離任,副行長莎倫·科齊基將於7月15日退休。馬克-安德烈·戈斯林和尼古拉斯·文森特將分別於2026年5月25日和8月3日加入管理委員會,擔任副行長。 戈斯林自2019年以來一直領導加拿大央行經濟分析部,此前曾擔任金融穩定部副總經理。 文森特目前已是管理委員會成員,自2023年以來一直擔任外部副行長。加拿大央行將啟動外部副行長職位的招聘程序,以填補即將空缺的職位。 4月份的會議成員人數因此只有六人,門德斯在會前離任,其繼任者要到5月25日才會加入。 瑞銀認為這對政策決定影響不大,理事會將在6月的會議上恢復滿員。雖然科齊基將於7月15日退休(與7月份政策公告同一天),但瑞銀預計她不會參加那次會議。屆時會議的出席成員是六人還是七人,將取決於空缺的外部副行長職位能否盡快填補。
Related Articles
Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.
Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.
Research Alert: CFRA Maintains Hold Opinion In Shares Of Wab
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target to $285 from $275 following WAB's Q1 earnings print, valuing shares at 24.2x our 2027 EPS outlook of $11.76 (revised from $11.46; 2026 EPS estimate up to $10.57 from $10.50), a slight premium to WAB's long-term historical multiple average given structural improvements in earnings quality. While we are cautious on signs of overcapacity in the freight market, an elevated order backlog (12-month sits at over $9 billion), internal initiatives to shore up margins, and potential synergies from M&A activity positions WAB to continue growing earnings at double-digit rates in 2026-2027, in our view. Despite tariff-related cost pressures, WAB has done a commendable job of defending margins via a mix of pricing, lean manufacturing, and pruning of lower-profit operations. Q1 results were mixed but overall positive, in our view. We maintain our Hold recommendation on shares.